New Aspects of Copper and Iron Metabolism in the Myelodysplastic Syndromes

Publisher： Karger

E-ISSN： 1421-9794|52|2|66-68

ISSN： 0009-3157

Source： Chemotherapy, Vol.52, Iss.2, 2006-04, pp. : 66-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Copper Oxidases and Human Iron Metabolism

By Vashchenko Ganna   MacGillivray Ross T. A.  

Nutrients, Vol. 5, Iss. 7, 2013-06 ,pp. : 2289-2313

MDPI

Access to resources Recommend Favorite

The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes

By Kittang Astrid Olsnes   Sand Kristoffer   Brenner Annette Katharina   Rye Kristin Paulsen   Bruserud Øystein  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1080-1080

MDPI

Access to resources Recommend Favorite

Efficacy of Oral Cytarabine Ocfosfate and Etoposide in the Treatment of Elderly Patients with Higher-Risk Myelodysplastic Syndromes Compared to That in Elderly Acute Myeloid Leukemia Patients

By  

Chemotherapy, Vol. 59, Iss. 2, 2013-09 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

The Functions of Metamorphic Metallothioneins in Zinc and Copper Metabolism

By Krężel Artur   Maret Wolfgang  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1237-1237

MDPI

Access to resources Recommend Favorite

Influence of microRNA on the Maintenance of Human Iron Metabolism

By Davis McKale   Clarke Stephen  

Nutrients, Vol. 5, Iss. 7, 2013-07 ,pp. : 2611-2628

MDPI

Access to resources Recommend Favorite